Behavioral and neurochemical responses in mice bearing tumors submitted to social stress

Behavioural Brain Research

Volumn 155, Issue 1, 2004, Pages 125-134

  Vegas, O ^a   Beitia, G ^a   Sanchez Martin J R ^a   Arregi, A ^a   Azpiroz, A ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

D2 receptors; Dopamine; Proliferative response; Serotonin; Social stress; Tumor

Indexed keywords

DOPAMINE 2 RECEPTOR;

AGGRESSION; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AVOIDANCE BEHAVIOR; BEHAVIOR; CANCER GRAFT; CELL PROLIFERATION; CONTROLLED STUDY; CORPUS STRIATUM; DEFENSIVE BEHAVIOR; DOPAMINERGIC ACTIVITY; EXPERIMENTAL MODEL; EXPERIMENTAL MOUSE; IMMOBILIZATION; INOCULATION; MALE; MELANOMA CELL; MONOAMINE NERVE CELL; MONONUCLEAR CELL; MOUSE; NEUROCHEMISTRY; NONHUMAN; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RECORDING; SAMPLE; SEROTONINERGIC SYSTEM; SOCIAL INTERACTION; SOCIAL PROBLEM; SPLEEN CELL; STATISTICAL SIGNIFICANCE; TUMOR;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; BINDING SITES; BIOGENIC MONOAMINES; BRAIN CHEMISTRY; CELL DIVISION; CELL LINE, TUMOR; INTERPERSONAL RELATIONS; LYMPHOCYTES; MALE; MELANOMA; MICE; MICE, INBRED C57BL; RANDOM ALLOCATION; RECEPTORS, DOPAMINE D2; STRESS, PSYCHOLOGICAL; TIME FACTORS;

EID: 4344587205     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2004.04.006     Document Type: Article

References (66)

1. Ader R., Cohen N. Psychoneuroimmunology: conditioning and stress. Annu. Rev. Psychol. 44:1993;53-85
2. Albonetti M.E., Farabollini F. Social stress by reat defeat: effects on social behaviour and emotionally. Behav. Brain Res. 62:1994;187-193
3. Anisman H., Kokkinidis L., Merali Z. Interleukin-2 decreases accumbal dopamine efflux and responding for rewarding lateral hypothalamic stimulation. Brain Res. 731:1996;1-11
4. Azpiroz A., Garmendia L., Fano E., Sánchez-Martin J.R. Relations between aggressive behavior, immune activity and disease susceptibility. Agress. Viol. Behav. 8:2003;433-453
5. Bardo M.T., Donohew A.J., Harrington N.G. Psychobiology of novelty and drug seeking behavior. Behav. Brain Res. 77:1996;23-43
6. Bellinger DL, Felten SY, Lorton D, Felten DL. Innervation of lymphoid organs and neurotransmitter-lymphocyte interactions. In: Hickey WF, editor. Immunology of the nervous system. New York: Oxford University Press; 1997. p. 226-329.
7. Besedovsky H.O., Del Rey A. Immune-neuro-endocrine interactions: facts and hypotheses. Endocr. Rev. 17:1996;64-102
8. Biondi M. Effects of stress on immune functions: an overview. In: Ader R, Felten DL, Cohen N, editors. Psychoneuroimmunology, vol 2. New York: Academic Press; 2001. p. 189-226.
9. Biondi M., Zannino L.G. Psychological stress, neuroimmunomodulation and susceptibility to infectious diseases in animals and man: a review. Psychother. Psychosom. 66:1997;3-26
10. Blalock EJ. Neuroimmunoendocrinology. Basilea: Karger; 1993.
11. Blanchard D.C., Cholvanich P., Blanchard R.J., Clow D.W., Hammer R.P., Rowlett J.K., et al. Serotonin but not dopamine metabolites are increased in selected brain regions of subordinate male rats in a colony environment. Brain Res. 568:1991;61-66
12. Blanchard D.C., Sakai R.R., McEwen B., Weiss S.M., Blanchard R.J. Subordination stress: behavioral, brain, and neuroendocrine correlates. Behav. Brain Res. 58(1-2):1993;113-121
13. Bluthé R.M., Pawlowski M., Suarez S., Parnet P., Pittman Q., Kelley K.W., et al. Synergy between tumor necrosis factor alpha and interleukin-1 in the induction of sickness behavior in mice. Psychoneuroendocrinology. 19:1994;197-207
14. Boehme R.E., Ciaranello R.D. Dopamine receptor binding in inbred mice: strain differences in mesolimbic and nigrostriatal dopamine binding sites. Proc. Natl. Acad. Sci. USA. 78:1981;3255-3259
15. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254
16. Brebner K., Haley S., Zacharko R., Merali Z., Anisman H. Synergistic effects of interleukin-1β, interlukin-6, and tumor necrosis factor-α: central monoamine, corticosterone, and behavioral variations. Neuropsychopharmacology. 22:2000;566-580
17. Chance W.T., von Meterfeldt M.F., Fischer J.E. Changes in brain amines associated with cancer anorexia. Neurosci. Biobehav. Rev. 7:2003;471-479
18. Chance W.T., Cao L., Fischer J.E. Tumor-induced alterations in brain neurotransmitter and plasma ammonia concentrations are normalized twenty-four hours after tumor resection. Life Sci. 48:1990;425-432
19. Chuluyan H.E., Wolcott R.M., Chervenak R., Dunn A.J. Catecholamine, indolamine and corticosteroid responses in mice bearing tumors. Neuroimmunomodulation. 8:2000;107-113
20. Cirulli F., De Acetis L., Alleva E. Behavioral effects of peripheral interlukin-1 administration in adult CD-1 mice: specific inhibition of the offensive components of intermale agonistic behavior. Brain Res. 79:1998;308-312
21. Connor T.J., Song C., Leonard B.E., Merali Z., Anisman H. An assessment of the effects of central interleukin-1β,-2,-6, and tumor necrosis factor-α administration on some behavioural, neurochemical, endocrine and immune parameters in the rat. Neuroscience. 84:1998;923-933
22. Dantzer R, Bluthé RM, Castanon N, Chauvet N, Capuron L, Goodall G, et al. Cytokine effects on behavior. In: Ader R, Felten DL, Cohen N, editors. Pychoneuroimmunology, vol 1. San Diego: Academic Press; 2001. p. 703-27.
23. Dantzer R, Bluthé RM, Aubert A, Goodall G, Bret-Dibat JL, Kent S, et al. Cytokine actions on behavior. In: Rothwell NJ, editor. Cytokines in the nervous system. New York: Chapman & Hall; 1996. p. 117-40.
24. Dantzer R., Kelley K.W. Stress and immunity: an integrated view of relationships between the brain and the immune system. Life Sci. 44:1989;1995-2008
25. Dunn A. Systemic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism paralleling the increased plasma corticosterone. Life Sci. 43:1988;429-435
26. Dunn A. Effects of cytokines and infections on brain neurochemistry. In: Ader R, Felten DL, Cohen N, editors. Psychoneuroimmunology. San Diego: Academic Press; 2001. p. 649-702.
27. Dunn A.J., Antoon M., Chapman Y. Reduction of exploratory behavior by intraperitoneal injection of interleukin-1 involves brain corticotropin- releasing factor. Brain Res. Bull. 26:1991;539-542
28. Dunn A.J. Endotoxin-induced activación of cerebral catecholamine and serotonine metabolism: comparison with interleukin-1. J. Pharmac. Exp. Ther. 261:1992;964-969
29. Dunn A.J., Chapman Y., Antoon M. Endotoxin-induced behavioral changes of mice in the multicompartment chamber are distinc from those of interleukin-1. Neurosci. Res. Commun. 10:1992;63-69
30. Dunn AJ, Wang J, Ando T. Effects of cytokines on cerebral neurotransmission. In: Dartzer R, Wollman EE, Yirmina R, editors. Cytokines, stress and depression. New York: Kluwer Academic/Plenum Publishers; 1999. p. 117-27.
31. 1A-synthesis modulating receptors following long-term administration of antidepressant drugs. Methods Find Exp. Clin. Pharmacol. 18:1996;46
32. Fano E., Sánchez-Martin J.R., Brain P.F. Ethologically-determined responses of male mice in new dyadic encounters reflect their previous 'social status'. Psicothema. 9:1997;391-397
33. Felten L., Livnat S., Felten S.Y., Carlson S.L., Bellinger D.L., Yeh P. Sympathetic innervation of lymphoid nodes in mice. Brain Res. Bull. 13:1984;693-699
34. Friedman E.M., Irwin M.R. Modulation of immune cell function by the autonomic nervous system. Pharmacol. Ther. 74:1997;27-38
35. Gemma C., Imeri L., Opp M.R. Serotonergic activation stimulates the pituitary-adrenal axis and alters interleukin-1 mRNA expression in rat brain. Psychoneuroendocrinology. 28:2003;875-884
36. Hart B.L. Biological basis of the behavior of sick animals. Neurosci. Biobehav. Rev. 12:1988;123-137
37. Homo-Delarche F, Durant S. Hormones neurotransmitters and neuropeptides as modulators of lymphocyte functions. In: Pleszczynski MR, editor. Immunopharmacology of lymphocytes. London: Academic Press Limited; 1994. p. 169-240.
38. Houghton A.N., Gold J.S., Blachere N.E. Immunity against cancer: lessons learned from melanoma. Curr. Opin. Immunol. 13:2001;134-140
39. Irwin M. Stress-induced immune suppression: role of brain corticotropin releasing hormone and autonomic nervous system mechanisms. Adv. Neuroimmunol. 4:1994;29-47
40. Isovich E., Engelman M., Landgraf R., Fuchs E. Social isolation after a single defeat reduces striatal dopamine transporter binding in rats. Eur. J. Neurosci. 13:2001;1254-1256
41. Jensen P., Hansen S., Moller B., Leivestad T., Pfeffer P., Geiran O., et al. Skin in kidney and heart transplant reciepients and different long-term immunosuppressive therapy regimens. J. Am. Acad. Dermatol. 40:1999;177-186
42. Kent S., Bluthé R.M., Kelley K.W., Dantzer R. Sickness behavior as a new target for drug development. Trends Pharmacol. Sci. 13:1992;24-28
43. Konsman J.P., Parnet P., Dantzer R. Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci. 25:2002;154-159
44. Kruger-Krasagakes S., Krasagakis K., Garbe C., Diamantstein T. Production of cytokines by human melanoma cells and melanocytes. Recent Results Cancer Res. 139:1995;155-168
45. Kudryavtseva N.N., Bakshtanovskaya I.V., Koryakina L.A. Social model of depression in mice of C57BL/6J strain. Psychopharmacol. Biochem. Behav. 38:1991;315-320
46. Lazar-Molmar E., Hegyesi H., Toth S., Falus A. Autocrine and paracrine regulation by cytokines and growth factors in melanoma. Cytokine. 12:2000;547-554
47. LeMoal M., Simon H. Mesocorticolimbic dopaminergic network: functional and regulatory roles. Physiol. Rev. 71:1991;155-234
48. Linthorst A.C.E., Flachskamm C., Holsboer F., Reul M.H.M. Activation of serotonergic and noradrenergic neurotransmission in the rat hippocampus after peripheral administration of bacterial endotoxin: involvement of the cyclo-oxygenase pathway. Neuroscience. 72:1996;989-997
49. Martinez M., Castaño D., Simón V., Brain P.F. An ethopharmacological assessment of the influences of cyproterone acetate on social interactions in male mice. IRSC Med. Sci. 14:1986;44-54
50. McEwen B.S., Biron C.A., Brunson K.W., Bulloch K., Chambers W.H. The role of adrenocorticoids as modulators of immune function in healt and disease: neural. Brain Res. Rev. 23:1997;79-133
51. Moynihan J.A., Ader R. Psychoneuroimmunology: animal models of disease. Psychosom. Med. 58:1996;546-558
52. Nicola NAE. Guidebook to cytokines and their receptors. Oxford: Oxford University Press; 1994.
53. Nistico G., De Sarro G. Is interleukin 2 a neuromodulator in the brain? Trends Neurosci. 14:1991;146-150
54. Petitto J.M., McCathy D.B., Rinker C.M., Huang Z., Getty T. Modulation of behavioral and neurochemical measures of forebrain dopamine function in mice by species-specific interleukin-2. J. Neuroinmmunol. 73:1997;183-190
55. Rabin BS. Stress, immune function and health. New York: John Wiley & Sons; 1999.
56. Robbins T.W., Everitt B.J. Functions of dopamine in the dorsal and ventral striatum. Semin. Neurosci. 4:1992;119-127
57. Rubistein M., Muschietti J.P., Gershanik O., Flawia M.M., Stefano F.J.E. Adaptative mechanisms of striatal D1 and D2 dopamine receptors in response to a prolonged reserpine treatment in mice. J. Pharmacol. Exp. Ther. 252:1990;810-816
58. Salzet M., Vieu D., Day R. Crosstal between nervous and immune system through the animal kingdom: focus on opioids. Trends Neurosci. 23:2000;550-555
59. Schedlowski M, Benschop J. Neuroendocrine system and immune functions. In: Tewes MS, editor. Psychoneuroimmunolgy: an interdisciplinary introduction. New York: Kluwer Academic/Plenum Publishers; 1999. p. 185-207.
60. Shintani F., Kanba S., Nakaki T., Nibuya N., Kinoshita N., Zuzuki E., et al. Interlukin-1 beta augments release of norepinephrine, dopamine, and serotonin in the rat anterior hypothalamus. J. Neurosci. 13:1993;3574-3581
61. Smagin G.N., Swiergiel A.H., Dunn A.J. Peripheral administration of interleukin-1 increases extracellular concentrations or norepinephrine in rat hypothalamus: comparison with plasma corticosterone. Psychoneuroendocrinology. 21:1996;83-93
62. Spadaro F., Dunn A.J. Intracerebroventricular administration of interleukin-1 to mice alters investigation of stimuli in a novel environment. Brain Behav. Immunol. 4:1990;308-322
63. Tornatzky W., Mickzek K.A. Behavioral and autonomic responses to intermittent social stress: differential protection by clonidine and metropolol. Psychopharmacology. 116:1994;346-356
64. Uomoto M., Nishibori M., Nakaya N., Takeuchi Y., Iwagaki H., Tanaka N., et al. Changes in monoamine turnover in the brain of cachetic mice bearing colon-26 cells. J. Neurochem. 70:1998;260-267
65. Zalcman S., Green-Johnson J.M., Murria L., Nance D.M., Dyck D., Anisman H., et al. Cytokine-specific central monoamine alterations induced by interleukin-1, 2 and 6. Brain Res. 643:1994;40-49
66. Zalcman S., Murray L., Dick D.G., Greenberg A.H., Nance D.M. Interleukin-2 and 6 induce behavioral-activating effects in mice. Brain Res. 811:1998;111-121